Literature DB >> 8256761

The reirradiation of recurrent bronchogenic carcinoma with external beam irradiation.

J F Montebello1, B S Aron, A K Manatunga, J L Horvath, F W Peyton.   

Abstract

Symptomatic local failure following thoracic irradiation for bronchogenic carcinoma presents a clinical challenge to the Radiation Oncologist. We retrospectively evaluated the efficiency of reirradiation with external beam radiation of 30 patients. The median dose of initial irradiation was 6,000 cGy in 6 weeks. The median time following initial irradiation to recurrence was 12 months. The median dose of retreatment was 3,030 cGy in 3 weeks. Of the symptomatic patients, 88% and 70% subjectively responded to initial irradiation and to reirradiation, respectively. Retreatment toxicity included radiation esophagitis (6 patients), dry desquamation (4 patients), and symptomatic radiation pneumonitis (1 patient). Based on this study, doses of external beam radiation in the range of 2,000-3,000 cGy in 2 to 3 weeks appear safe and effective in reirradiating recurrent bronchogenic carcinoma.

Entities:  

Mesh:

Year:  1993        PMID: 8256761     DOI: 10.1097/00000421-199312000-00004

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  12 in total

1.  Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation.

Authors:  Patrick Kelly; Peter A Balter; Neal Rebueno; Hadley J Sharp; Zhongxing Liao; Ritsuko Komaki; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-08       Impact factor: 7.038

2.  Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment.

Authors:  Jeremy M Kilburn; Jeffrey G Kuremsky; A William Blackstock; Michael T Munley; William T Kearns; William H Hinson; James F Lovato; Antonius A Miller; William J Petty; James J Urbanic
Journal:  Radiother Oncol       Date:  2014-01-17       Impact factor: 6.280

3.  Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy.

Authors:  Takuhito Tada; Haruyuki Fukuda; Kaoru Matsui; Tomonori Hirashima; Masako Hosono; Yoshie Takada; Yuichi Inoue
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

Review 4.  Special topics in immunotherapy and radiation therapy: reirradiation and palliation.

Authors:  Tracey Evans; Christine Ciunci; Lauren Hertan; Daniel Gomez
Journal:  Transl Lung Cancer Res       Date:  2017-04

5.  Reirradiation for locoregionally recurrent lung cancer: outcomes in small cell and non-small cell lung carcinoma.

Authors:  Tim J Kruser; Bradley P McCabe; Minesh P Mehta; Deepak Khuntia; Toby C Campbell; Heather M Geye; George M Cannon
Journal:  Am J Clin Oncol       Date:  2014-02       Impact factor: 2.339

6.  Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer.

Authors:  Jeremy M Kilburn; Scott C Lester; John T Lucas; Michael H Soike; A William Blackstock; William T Kearns; William H Hinson; Antonius A Miller; William J Petty; Michael T Munley; James J Urbanic
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609

Review 7.  Reirradiation for locoregionally recurrent non-small cell lung cancer.

Authors:  Melissa A L Vyfhuis; Stephanie Rice; Jill Remick; Sina Mossahebi; Shahed Badiyan; Pranshu Mohindra; Charles B Simone
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

8.  Esophageal tolerance to high-dose stereotactic radiosurgery.

Authors:  Bo Mi Lee; Sei Kyung Chang; Seung Young Ko; Seung Hoon Yoo; Hyun Soo Shin
Journal:  Radiat Oncol J       Date:  2013-12-31

9.  Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis.

Authors:  Brane Grambozov; Evelyn Nussdorfer; Julia Kaiser; Sabine Gerum; Gerd Fastner; Markus Stana; Christoph Gaisberger; Romana Wass; Michael Studnicka; Felix Sedlmayer; Franz Zehentmayr
Journal:  Curr Oncol       Date:  2021-05-13       Impact factor: 3.677

10.  Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT).

Authors:  Marsha Reyngold; Abraham J Wu; Amanda McLane; Zhigang Zhang; Meier Hsu; Nicholas F Stein; Ying Zhou; Alice Y Ho; Kenneth E Rosenzweig; Ellen D Yorke; Andreas Rimner
Journal:  Radiat Oncol       Date:  2013-04-25       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.